AAAAAA
Results:
1-7
|
Results: 7
Authors:
LEYLANDJONES B
KELLAND L
SHARP S
HIORNS L
Citation: B. Leylandjones et al., GENOMIC IMBALANCES ASSOCIATED WITH ACQUIRED-RESISTANCE TO PLATINUM ANALOGS, European journal of human genetics, 6, 1998, pp. 2072-2072
Authors:
WORKMAN P
KELLAND L
Citation: P. Workman et L. Kelland, PRECLINICAL ASSESSMENT - SHOULD WE MODIFY OUR PRECLINICAL EVALUATION FOR AGENTS AIMED AT NEW MOLECULAR TARGETS, Annals of oncology, 9, 1998, pp. 18-18
Authors:
BRADSHAW TD
SCHULTZ RJ
PAULL KD
KELLAND L
WILSON A
GARNER C
FIEBIG HH
WRIGLEY S
STEVENS MFG
Citation: Td. Bradshaw et al., INFLUENCE OF 2-(4-AMINOPHENYL)BENZOTHIAZOLES ON GROWTH OF HUMAN OVARIAN-CARCINOMA CELLS IN-VITRO AND IN-VIVO, British Journal of Cancer, 78(4), 1998, pp. 421-429
Authors:
BEALE P
ROGERS P
HOBBS S
BOXALL F
KELLAND L
Citation: P. Beale et al., TRANSFECTION OF BAX INTO RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINESCONFERS NO SENSITIZATION TO CHEMOTHERAPEUTIC-AGENTS, British Journal of Cancer, 78, 1998, pp. 23-23
Authors:
ZWEIT J
LEWIS J
DEARLING J
ROONEY B
BLOWER P
COLEY H
KELLAND L
Citation: J. Zweit et al., COPPER-64-DIPHOSPHINE COMPLEXES - POTENTIAL PET TRACERS FOR THE ASSESSMENT OF MULTIDRUG-RESISTANCE IN TUMORS, The Journal of nuclear medicine, 38(5), 1997, pp. 499-499
Authors:
JUDSON I
MCKEAGE M
RAYNAUD F
KELLAND L
HANLEY J
BERRY C
ODELL D
MURRER B
HARRAP K
Citation: I. Judson et al., THE DEVELOPMENT OF NEW PLATINUM COMPLEXES - ORAL DELIVERY AND NON-CROSS RESISTANCE, European journal of cancer, 31A, 1995, pp. 981-981
Authors:
GORE M
BRIDGEWATER J
CHANG J
SCHOFIELD J
FISHER C
JACOBS I
PONDER B
AHERN R
MCKEAGE M
KELLAND L
HARRAP K
Citation: M. Gore et al., NONSURGICAL ASPECTS OF OVARIAN-CANCER, Lancet, 343(8893), 1994, pp. 335-340
Risultati:
1-7
|